A biomimetic nanoparticle-enabled toxoid vaccine against melittin

 Tianyi Kang,1 Chenyang Li,1,2 Ting Du,1 Yujiao Wu,1 Yuping Yang,1 Xuan Liu,1 Qianqian Zhang,1 Xiaoping Xu,3 Maling Gou1,4 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China; 2Shanghai Institu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kang T, Li C, Du T, Wu Y, Yang Y, Liu X, Zhang Q, Xu X, Gou M
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/65f8694c6d874dc59e11f0ba94b896be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:65f8694c6d874dc59e11f0ba94b896be
record_format dspace
spelling oai:doaj.org-article:65f8694c6d874dc59e11f0ba94b896be2021-12-02T09:02:47ZA biomimetic nanoparticle-enabled toxoid vaccine against melittin1178-2013https://doaj.org/article/65f8694c6d874dc59e11f0ba94b896be2018-06-01T00:00:00Zhttps://www.dovepress.com/a-biomimetic-nanoparticle-enabled-toxoid-vaccine-against-melittin-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Tianyi Kang,1 Chenyang Li,1,2 Ting Du,1 Yujiao Wu,1 Yuping Yang,1 Xuan Liu,1 Qianqian Zhang,1 Xiaoping Xu,3 Maling Gou1,4 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China; 2Shanghai Institutes for Biological Science, Chinese Academy of Science, Shanghai 200031, People’s Republic of China; 3West China School of Pharmacy, Sichuan University, Chengdu 610041, People’s Republic of China; 4Co-Innovation Center for Micro/Nano Optoelectronic Materials and Devices, Chongqing 402160, People’s Republic of China Background: Melittin, the main active peptide ingredient of bee venom, can cause severe cell membrane lysis due to its robust interaction with negatively charged phospholipids. So far, no effective anti-melittin vaccine has been developed to protect people from undesired melittin intoxication.Methods: Herein, we prepared a polydiacetylene (PDA) nanoparticle with cell membrane-mimic surface to complex melittin, forming an anti-melittin vaccine (PDA–melittin).Results: PDA nanoparticles could effectively combine with melittin and neutralize its toxicity. PDA–melittin nanocomplex is demonstrated to enhance melittin uptake by DCs and stimulate strong melittin-specific immunity. Mice immunized with PDA–melittin nanocomplex showed higher survival rate after exposion to melittin than untreated mice.Conclusion: The PDA–melittin nanocomplex can efficiently and safely generate a specific immunity against melittin to protect body from melittin intoxication, providing a new method with potential clinical application for the treatment of melittin intoxication.Keywords: PDA nanoparticles, melittin, toxoid vaccine, immunityKang TLi CDu TWu YYang YLiu XZhang QXu XGou MDove Medical PressarticlePDA nanoparticlesMelittinToxoid VaccineImmunityMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 3251-3261 (2018)
institution DOAJ
collection DOAJ
language EN
topic PDA nanoparticles
Melittin
Toxoid Vaccine
Immunity
Medicine (General)
R5-920
spellingShingle PDA nanoparticles
Melittin
Toxoid Vaccine
Immunity
Medicine (General)
R5-920
Kang T
Li C
Du T
Wu Y
Yang Y
Liu X
Zhang Q
Xu X
Gou M
A biomimetic nanoparticle-enabled toxoid vaccine against melittin
description  Tianyi Kang,1 Chenyang Li,1,2 Ting Du,1 Yujiao Wu,1 Yuping Yang,1 Xuan Liu,1 Qianqian Zhang,1 Xiaoping Xu,3 Maling Gou1,4 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China; 2Shanghai Institutes for Biological Science, Chinese Academy of Science, Shanghai 200031, People’s Republic of China; 3West China School of Pharmacy, Sichuan University, Chengdu 610041, People’s Republic of China; 4Co-Innovation Center for Micro/Nano Optoelectronic Materials and Devices, Chongqing 402160, People’s Republic of China Background: Melittin, the main active peptide ingredient of bee venom, can cause severe cell membrane lysis due to its robust interaction with negatively charged phospholipids. So far, no effective anti-melittin vaccine has been developed to protect people from undesired melittin intoxication.Methods: Herein, we prepared a polydiacetylene (PDA) nanoparticle with cell membrane-mimic surface to complex melittin, forming an anti-melittin vaccine (PDA–melittin).Results: PDA nanoparticles could effectively combine with melittin and neutralize its toxicity. PDA–melittin nanocomplex is demonstrated to enhance melittin uptake by DCs and stimulate strong melittin-specific immunity. Mice immunized with PDA–melittin nanocomplex showed higher survival rate after exposion to melittin than untreated mice.Conclusion: The PDA–melittin nanocomplex can efficiently and safely generate a specific immunity against melittin to protect body from melittin intoxication, providing a new method with potential clinical application for the treatment of melittin intoxication.Keywords: PDA nanoparticles, melittin, toxoid vaccine, immunity
format article
author Kang T
Li C
Du T
Wu Y
Yang Y
Liu X
Zhang Q
Xu X
Gou M
author_facet Kang T
Li C
Du T
Wu Y
Yang Y
Liu X
Zhang Q
Xu X
Gou M
author_sort Kang T
title A biomimetic nanoparticle-enabled toxoid vaccine against melittin
title_short A biomimetic nanoparticle-enabled toxoid vaccine against melittin
title_full A biomimetic nanoparticle-enabled toxoid vaccine against melittin
title_fullStr A biomimetic nanoparticle-enabled toxoid vaccine against melittin
title_full_unstemmed A biomimetic nanoparticle-enabled toxoid vaccine against melittin
title_sort biomimetic nanoparticle-enabled toxoid vaccine against melittin
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/65f8694c6d874dc59e11f0ba94b896be
work_keys_str_mv AT kangt abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT lic abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT dut abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT wuy abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT yangy abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT liux abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT zhangq abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT xux abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT goum abiomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT kangt biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT lic biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT dut biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT wuy biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT yangy biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT liux biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT zhangq biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT xux biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
AT goum biomimeticnanoparticleenabledtoxoidvaccineagainstmelittin
_version_ 1718398247653867520